Brandinium

Trademark search for:

OMEPRASON

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2003-12-19 — Application filed
  • 2004-01-08 — Application filed
  • 2004-03-02 — Final disposition recorded
  • 2004-03-02 — Assigned to examiner
  • 2004-03-26 — Teas change of correspondence received
  • 2004-08-19 — Paper received
  • 2004-08-19 — Correspondence received in law office
  • 2004-09-19 — Amendment from applicant entered
  • 2004-09-19 — Assigned to lie
  • 2004-10-19 — Approved for pub - principal register
  • 2004-11-01 — Assigned to lie
  • 2004-11-02 — Law office publication review completed
  • 2004-12-15 — Notice of publication
  • 2005-01-04 — Published for opposition
  • 2005-03-29 — Noa mailed - sou required from applicant
  • 2005-09-28 — Sou teas extension received
  • 2005-09-28 — Sou extension 1 filed
  • 2005-10-07 — Sou extension 1 granted
  • 2006-03-27 — Sou teas extension received
  • 2006-03-27 — Sou extension 2 filed
  • 2006-04-15 — Sou extension 2 granted
  • 2006-06-02 — Teas change of correspondence received
  • 2006-09-05 — Sou teas extension received
  • 2006-09-05 — Sou extension 3 filed
  • 2006-09-29 — Sou extension 3 granted
  • 2007-03-28 — Sou teas extension received
  • 2007-03-28 — Sou extension 4 filed
  • 2007-07-12 — Sou extension 4 granted
  • 2007-07-24 — Attorney/dom.rep.revoked and/or appointed
  • 2007-07-24 — Teas revoke/app/change addr of atty/dom rep received
  • 2007-09-30 — Final status recorded
  • 2007-12-07 — Application abandoned
  • 2007-12-12 — Application abandoned

Owner Information

AstraZeneca AB
Sodertalje SE
AstraZeneca AB
Sodertalje SE

Correspondent

Wm. Charles Saunders AstraZeneca Pharmaceuticals LP
1800 Concord Pike
OW2
Wilmington, DE 19850

Filing Details

Filing Date:
2003-12-19
Status Date:
2007-09-30
Category:
Pharmaceuticals
Filing Year:
2000

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.